San Francisco, CA, United States of America

Frank Charbonier

This inventor holds 1 USPTO granted patent. Top assignee: Cellanome, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank Charbonier: Innovator in Biological Sample Analysis

Introduction

Frank Charbonier is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biological analysis through his innovative patent. His work focuses on developing systems that enhance the analysis of biological components, which can have far-reaching implications in various scientific fields.

Latest Patents

Frank Charbonier holds a patent for "Devices and methods for analyzing biological samples." This patent describes systems that include a fluidic device and an energy source in communication with the fluidic device. The energy source supplies energy to the fluidic device to form a polymer matrix on or adjacent to a biological component within the fluidic device. The methods outlined in this patent provide new ways to analyze biological components effectively.

Career Highlights

Charbonier is currently associated with Cellanome, Inc., where he continues to push the boundaries of innovation in biological analysis. His work at Cellanome, Inc. reflects his commitment to advancing technology in the life sciences sector.

Collaborations

Some of his notable coworkers include Seyedsina Moeinzadeh and Justin Poelma, who contribute to the collaborative environment that fosters innovation at Cellanome, Inc.

Conclusion

Frank Charbonier's contributions to the field of biological sample analysis through his patent and work at Cellanome, Inc. highlight his role as an influential inventor. His innovative systems and methods are paving the way for advancements in biological research and analysis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…